233 related articles for article (PubMed ID: 26965362)
1. Therapeutic Application of Percutaneous Peritoneovenous (Denver) Shunt in Treating Chylous Ascites in Cancer Patients.
Yarmohammadi H; Brody LA; Erinjeri JP; Covey AM; Boas FE; Ziv E; Maybody M; Gonzalez-Aguirre AJ; Brown KT; Sheinfeld J; Getrajdman GI
J Vasc Interv Radiol; 2016 May; 27(5):665-73. PubMed ID: 26965362
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Chylous Ascites with Peritoneovenous Shunt (Denver Shunt) following Retroperitoneal Lymph Node Dissection in Patients with Urological Malignancies: Update of Efficacy and Predictors of Complications.
Yarmohammadi H; Schilsky J; Durack JC; Brody LA; Asenbaum U; Velayati S; Santos E; Gonzalez-Aguirre AJ; Erinjeri JP; Petre N; Solomon SB; Sheinfeld J; Getrajdman GI
J Urol; 2020 Oct; 204(4):818-823. PubMed ID: 32364837
[TBL] [Abstract][Full Text] [Related]
3. Management of refractory chylous ascites with peritoneovenous shunts.
Huang Y; Gloviczki P; Duncan AA; Fleming MD; Driscoll DJ; Kalra M; Oderich GS; Bower TC
J Vasc Surg Venous Lymphat Disord; 2017 Jul; 5(4):538-546. PubMed ID: 28623993
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic results of Denver percutaneous peritoneovenous shunt in cancer patients with malignant ascites.
Tamagawa H; Aoyama T; Inoue H; Fujikawa H; Sawazaki S; Numata M; Sato T; Oshima T; Yukawa N; Morimoto M; Ueno M; Rino Y; Masuda M
J Cancer Res Ther; 2020 Dec; 16(Supplement):S95-S98. PubMed ID: 33380660
[TBL] [Abstract][Full Text] [Related]
5. Peritoneovenous shunting for intractable ascites.
Tyden G; Samnegård H; Thulin L
Acta Chir Scand; 1982; 148(7):597-600. PubMed ID: 7168289
[TBL] [Abstract][Full Text] [Related]
6. Chylous ascites: resolution after Denver peritoneovenous shunt.
Turner WW
South Med J; 1983 Apr; 76(4):539. PubMed ID: 6601302
[TBL] [Abstract][Full Text] [Related]
7. Radiological insertion of Denver peritoneovenous shunts for malignant refractory ascites: a retrospective multicenter study (JIVROSG-0809).
Sugawara S; Sone M; Arai Y; Sakamoto N; Aramaki T; Sato Y; Inaba Y; Takeuchi Y; Ueno T; Matsueda K; Moriguchi M; Tsushima T
Cardiovasc Intervent Radiol; 2011 Oct; 34(5):980-8. PubMed ID: 21191592
[TBL] [Abstract][Full Text] [Related]
8. Chylous ascites after post-chemotherapy retroperitoneal lymph node dissection: review of the M. D. Anderson experience.
Evans JG; Spiess PE; Kamat AM; Wood CG; Hernandez M; Pettaway CA; Dinney CP; Pisters LL
J Urol; 2006 Oct; 176(4 Pt 1):1463-7. PubMed ID: 16952661
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous central venous thrombosis and shunt occlusion following peritoneovenous shunt placement for intractable ascites.
Hariharan D; Wilkes EA; Aithal GP; Travis SJ; Lobo DN
Ann R Coll Surg Engl; 2017 May; 99(5):e145-e147. PubMed ID: 28462645
[TBL] [Abstract][Full Text] [Related]
10. Peritoneovenous shunts palliate malignant ascites.
Edney JA; Hill A; Armstrong D
Am J Surg; 1989 Dec; 158(6):598-601. PubMed ID: 2480068
[TBL] [Abstract][Full Text] [Related]
11. Palliative treatment of malignant refractory ascites by positioning of Denver peritoneovenous shunt.
Zanon C; Grosso M; Aprà F; Clara R; Bortolini M; Quaglino F; Cornaglia S; Simone P
Tumori; 2002; 88(2):123-7. PubMed ID: 12088251
[TBL] [Abstract][Full Text] [Related]
12. Thrombocytopenia and laboratory evidence of disseminated intravascular coagulation after shunts for ascites in malignant disease.
Tempero MA; Davis RB; Reed E; Edney J
Cancer; 1985 Jun; 55(11):2718-21. PubMed ID: 3995480
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous peritoneovenous shunt for treatment of refractory ascites.
Won JY; Choi SY; Ko HK; Kim SH; Lee KH; Lee JT; Lee DY
J Vasc Interv Radiol; 2008 Dec; 19(12):1717-22. PubMed ID: 18948021
[TBL] [Abstract][Full Text] [Related]
14. Palliation of malignant ascites by the Denver peritoneovenous shunt.
Downing R; Black J; Windsor CW
Ann R Coll Surg Engl; 1984 Sep; 66(5):340-3. PubMed ID: 6207757
[TBL] [Abstract][Full Text] [Related]
15. Peritoneovenous shunting for cirrhotic versus malignant ascites.
Kostroff KM; Ross DW; Davis JM
Surg Gynecol Obstet; 1985 Sep; 161(3):204-8. PubMed ID: 2412302
[TBL] [Abstract][Full Text] [Related]
16. Prognosis assessment of patients with refractory ascites treated with a peritoneovenous shunt.
Nitta H; Okamura S; Mizumoto T; Matsushita H; Nishimura T; Shimokawa Y; Kimura M; Baba H
Hepatogastroenterology; 2013 Oct; 60(127):1607-10. PubMed ID: 24634930
[TBL] [Abstract][Full Text] [Related]
17. Chronological Course and Clinical Features after Denver Peritoneovenous Shunt Placement in Decompensated Liver Cirrhosis.
Koyama S; Nogami A; Yoneda M; Cheng S; Koike Y; Takeuchi Y; Iwaki M; Kobayashi T; Saito S; Utsunomiya D; Nakajima A
Tomography; 2024 Mar; 10(4):471-479. PubMed ID: 38668394
[TBL] [Abstract][Full Text] [Related]
18. Peritoneovenous shunt for chylous ascites after lung transplantation for lymphangioleiomyomatosis.
Kanou T; Nakagiri T; Minami M; Inoue M; Shintani Y; Okumura M
Transplant Proc; 2012 Jun; 44(5):1390-3. PubMed ID: 22664021
[TBL] [Abstract][Full Text] [Related]
19. Improved quality of life for malignant ascites patients by Denver peritoneovenous shunts.
Tomiyama K; Takahashi M; Fujii T; Kunisue H; Kanaya Y; Maruyama S; Yokoyama N; Nakao A; Soda M; Shimizu N
Anticancer Res; 2006; 26(3B):2393-5. PubMed ID: 16821622
[TBL] [Abstract][Full Text] [Related]
20. Extracorporeal peritoneovenous shunt for the management of postaneurysmectomy chylous ascites in a Marfan patient.
Di Luozzo G; Scurlock C; Mechanick JI; Griepp RB
Ann Thorac Surg; 2010 Jul; 90(1):281-4. PubMed ID: 20609797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
